Addictions
Gabapentin
Gabapentin is a prescription medication with legitimate medical uses, but misuse and dependence can occur. Learn how to recognize concerning patterns, why abrupt discontinuation or combining substances can be risky, and where to find individualized support.
A Peaceful You Awaits
Featured Services
Mental Health Conditions
Get Help Today
Can Gabapentin Be Addictive?
Gabapentin is a prescription medication used for certain seizure disorders and nerve pain. Many people take it as directed without developing a problem. However, gabapentin can be misused, and repeated use may lead to physical dependence. Some people take more than prescribed, use it without a prescription, or combine it with other substances to change or intensify how they feel.
Physical dependence and addiction are related but not identical. Dependence means the body has adapted to a medication and may react when the dose is reduced or stopped. Addiction involves a pattern of compulsive use, impaired control, and continued use despite harm. A person can be physically dependent on a prescribed medication without having an addiction, which is why an individual assessment matters.
Signs of Gabapentin Misuse or Addiction
There is no single sign that proves someone has a problem with gabapentin. Patterns that may warrant a professional assessment include:
- Taking larger or more frequent doses than prescribed
- Using gabapentin without a prescription or obtaining it from multiple sources
- Feeling unable to cut back despite wanting to
- Craving the medication or spending significant time obtaining and using it
- Combining gabapentin with opioids, alcohol, benzodiazepines, or other sedating substances
- Continuing use despite problems with health, relationships, work, school, or responsibilities
- Experiencing withdrawal symptoms or feeling that normal functioning depends on the medication
Changes in alertness, coordination, mood, memory, or sleep can have many causes. A medical professional can review the full picture, including the prescribed dose, other medications, substance use, and underlying health conditions.
Gabapentin Withdrawal and the Risk of Stopping Suddenly
Withdrawal symptoms have been reported after gabapentin is stopped, particularly after ongoing or high-dose use. Abrupt discontinuation can also increase seizure risk, including for people who take gabapentin to control seizures. Do not stop or rapidly reduce prescribed gabapentin without speaking with the prescribing clinician. A provider can determine whether a gradual, medically supervised reduction is appropriate.
Possible withdrawal experiences vary and may include anxiety, agitation, sleep disruption, sweating, nausea, pain, or other changes. Symptoms alone do not establish addiction, but they are a reason to seek medical guidance. Treatment should account for the reason gabapentin was prescribed so that pain, seizures, or another underlying condition are not left unmanaged.
Mixing Gabapentin With Opioids or Other Sedatives
The most urgent risk is slowed or difficult breathing, especially when gabapentin is taken with opioids or other central nervous system depressants. The U.S. Food and Drug Administration warns that breathing problems are more likely when these substances are combined or when a person has respiratory risk factors.
Call 911 if someone is difficult to wake, has slow or shallow breathing, has blue or gray lips or fingertips, collapses, or may have overdosed. Tell emergency responders what substances may have been taken. If opioids could be involved and naloxone is available, administer it while emergency help is on the way.
How Gabapentin Misuse Is Treated
Treatment begins with a confidential assessment of medication use, other substances, physical health, mental health, and safety risks. Depending on the findings, a plan may include medical monitoring, a clinician-directed taper, residential or outpatient care, individual and group therapy, relapse-prevention skills, and support for pain or other conditions that contributed to use.
When gabapentin misuse occurs alongside opioid, alcohol, or benzodiazepine use, the plan must address every substance involved. It should also account for anxiety, depression, trauma, chronic pain, and sleep problems when they are present. Treating only the medication use without addressing these underlying drivers can leave a person vulnerable to returning to the same cycle.
Individualized Care at Compass Recovery
Compass Recovery provides addiction and dual diagnosis treatment in Cypress for people throughout Orange County and Southern California. We do not assume that every person who takes gabapentin needs the same level of care. The treatment plan is based on clinical needs, safety, history, strengths, and recovery goals.
Our approach combines evidence-informed therapy with experiential and movement-based care. Clients work on practical coping skills while exploring the deeper experiences and patterns that may be driving substance use. Purpose discovery is integrated into treatment so recovery is connected to a meaningful life beyond the treatment setting.
Talk With Someone About Your Options
If gabapentin use feels difficult to control, involves other substances, or is affecting daily life, a confidential conversation can help clarify the next step. Call Compass Recovery at (949) 444-9047 or contact our admissions team. Support is available 24/7.
This information is educational and does not replace advice from the clinician who prescribed your medication. Do not change a prescription without medical guidance. Call 911 for trouble breathing, loss of consciousness, a seizure, or another immediate emergency.
Our services
Comprehensive Holistic Addiction Treatment
Schedule your visit online
Take the next step and schedule an appointment today
Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.
Please do not include detailed medical information in this form. Information you submit is handled according to our Privacy Policy and Notice of Privacy Practices.

